Monday, 28 October 2019

AstraZeneca cancer drug combo meets late-stage trial goal

AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)